Profesor Dr. Alaattin YILDIZ

Áreas de interés médico

• Trasplante renal
• Hemodiálisis
• Nefropatía diabética
• Nefrología clínica
• Enfermedades glomerulares

Trayectoria

Formación

• Profesör: İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Nefroloji Bilim Dalı 2003-
• Doçent: İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Nefroloji Bilim Dalı 1996-2003
• Nefroloji Uzmanı: İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Nefroloji Bilim Dalı 1992-1996
• İç Hastalıkları Uzmanı: İstanbul Üniversitesi, İstanbul Tıp Fakültesi, İç Hastalıkları Anabilim Dalı 1987-1992
• Tıp Doktoru: İstanbul Üniversitesi, İstanbul Tıp Fakültesi 1987-1992

Experiencia

• Ekim 1995 – Şubat 1996:Harvard Medical School, Massachusetts General Hospital, Boston, USA’de klinik nefroloji ve transplantasyon alanında çalıştım.Aralık 2001 – Mayıs 2004:Vanderbilt University Medical Center, Nashville, TN, USA’de diyabetik nefropati ve podosit biyolojisi konularında ISN fellow olarak çalıştım.

Idiomas

• İngilizce

Información de honorarios

Llama para conocer los honorarios de consulta.

Métodos de pago

• Efectivo
• Tarjeta de crédito
• Transferencia bancaria

Direcciones

Cómo llegar

Publicaciones científicas

Membresías científicas

• Avrupa Nefroloji DerneğiTürk Nefroloji DerneğiDünya Nefroloji DerneğiGüncel Böbrek Hastalıkları Derneği

Publicaciones

• SCIE Dergilerde Çıkan Yayın listesi :
• 1: Ekşioğlu-Demiralp E, Alan S, Sili U, Bakan D, Ocak İ, Yürekli R, Alpay N, Görçin S, Yıldız A. Peripheral innate and adaptive immune cells during COVID-19: Functional neutrophils, pro-inflammatory monocytes, and half-dead lymphocytes. Cytometry B Clin Cytom. 2021 Nov 30. doi: 10.1002/cyto.b.22042.
• 2: Ozkok A, Alpay N, Alan S, Bakan ND, Soysal F, Yazici H, Ekşioğlu-Demiralp E, Yildiz A. Immunological parameters associated with the severity of COVID-19 pneumonia in kidney transplant recipients. Int Urol Nephrol. 2021 Aug 20:1–12. doi: 10.1007/s11255-021-02947-y.
• 3: Ozturk S, Turgutalp K, Arici M, ve ark. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study. Int J Clin Pract. 2021 Sep;75(9):e14428. doi: 10.1111/ijcp.14428. Epub 2021 Jun 17.
• 4: Chertow GM, Pergola PE, Farag YMK, ve ark. PRO2TECT Study Group. Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. N Engl J Med. 2021 Apr 29;384(17):1589-1600.
• doi: 10.1056/NEJMoa2035938
• 5: Oto OA, Ozturk S, Turgutalp K, ve ark. Predicting the outcome of COVID-19 infection in kidney transplant recipients. BMC Nephrol. 2021 Mar 19;22(1):100. doi: 10.1186/s12882-021-02299-w.
• 6: Turgutalp K, Ozturk S, Arici M ve ark. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021 Jan 14;22(1):29. doi:10.1186/s12882-021-02233-0.
• 7: Ozturk S, Turgutalp K, Arici M, ve ark. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
• Nephrol Dial Transplant. 2020 Dec 4;35(12):2083-2095. doi: 10.1093/ndt/gfaa271.
• 8: Ozkok A, Atas R, Cinar SA, Yilmaz A, Aktas E, Deniz G, Yildiz A. CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients. BMC Nephrol. 2017 Jul 26;18(1):250. doi: 10.1186/s12882-017-0663-x.
• 9: Yilmaz BA, Caliskan Y, Yilmaz A, Ozkok A, Bilge AK, Deniz G, Sariyar M, Yildiz A. Cardiovascular-renal changes after kidney donation: one-year follow-up study. Transplantation. 2015 Apr;99(4):760-4. doi: 10.1097/TP.0000000000000414.
• 10: Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol. 2014 Jun 28;20(24):7544-54. doi: 10.3748/wjg.v20.i24.7544.
• 11: Alpay N, Ozkok A, Caliskan Y, Akagun T, Cinar SA, Deniz G, Sariyar M, Yildiz A. Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients. Clin Exp Nephrol. 2014 Dec;18(6):961-7. doi: 10.1007/s10157-014-0939-4. Epub 2014 Feb 11.
• 12: Ozkok A, Kekik C, Karahan GE, Sakaci T, Ozel A, Unsal A, Yildiz A. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol. 2013 Nov 1;14:241. doi: 10.1186/1471-2369-14-241.
• 13: Ozkok A, Aktas E, Yilmaz A, Telci A, Oflaz H, Deniz G, Yildiz A. Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients. Clin Nephrol. 2013 Jan;79(1):21-30. doi: 10.5414/CN107318.
• 14: Caliskan Y, Yelken B, Ozkok A, Gorgulu N, Yazici H, Telci A, Yildiz A. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C. BMC Nephrol. 2012 Jul 7;13:56. doi: 10.1186/1471-2369-13-56.
• 15: Caliskan Y, Yildiz A. Evaluation of the medically complex living kidney donor. J Transplant. 2012;2012:450471. doi: 10.1155/2012/450471. Epub 2012 May 13.
• 16: Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, Ozel A, Unsal A, Yildiz A. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol. 2012 Jun;7(6):965-73. doi: 10.2215/CJN.11191111. Epub 2012 Apr 5.
• 17: Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, Oflaz H, Yildiz A. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol. 2012 Apr;77(4):275-82. doi: 10.5414/cn107352.
• 18: Yazici H, Oflaz H, Pusuroglu H, Tepe S, Dogan C, Basci A, Akkaya V, Yildiz A. Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients. Int Urol Nephrol. 2012 Aug;44(4):1203-10. doi: 10.1007/s11255-011-0024-9. Epub 2011 Jul 5.
• 19: Koc M, Dogan C, Arinsoy T, Tonbul Z, Ayli D, Cirit M, Sever MS, Yilmaz ME, Unsal A, Suleymanlar G, Ok E, Basci A, Yildiz A. Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients. Hemodial Int. 2011 Jul;15(3):366-73. doi:10.1111/j.1542-4758.2011.00547.x. Epub 2011 Apr 20.
• 20: Caliskan Y, Demirturk M, Ozkok A, Yelken B, Sakaci T, Oflaz H, Unsal A, Yildiz A. Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant. 2010 Aug;25(8):2685-90. doi:10.1093/ndt/gfq113. Epub 2010 Feb 26.
• 21: Caliskan Y, Oflaz H, Demirturk M, Yazici H, Turkmen A, Cimen A, Elitok A, Yildiz A. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clin Transplant. 2008 Nov-Dec;22(6):785-93. doi:10.1111/j.1399-0012.2008.00879.x.
• 22: Ozturk S, Taymez DG, Bahat G, Demirel R, Yazici H, Aysuna N, Sakar S, Yildiz A. The influence of low dialysate sodium and glucose concentration on volüme distributions in body compartments after haemodialysis: a bioimpedance analysis study. Nephrol Dial Transplant. 2008 Nov;23(11):3629-34. doi: 10.1093/ndt/gfn274. Epub 2008 May 28.
• 23: Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F,
• Tepe S. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant. 2005 Apr;20(4):760-7. doi: 10.1093/ndt/gfh611. Epub 2005 Feb 16.
• 24: Yildiz A, Tepe S, Oflaz H, Yazici H, Pusuroglu H, Besler M, Ark E, Erzengin F. Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant. 2004 Apr;19(4):885-91. doi: 10.1093/ndt/gfh001.
• 25: Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J Biol Chem. 2003 Nov 21;278(47):46616-24. doi: 10.1074/jbc.M307155200. Epub 2003 Sep 15.
• 26: Yildiz A, Oflaz H, Pusuroglu H, Mercanoglu F, Genchallac H, Akkaya V, Ikizler TA, Sever MS. Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis. 2003 Mar;41(3):616-23. doi: 10.1053/ajkd.2003.50123.
• 27: Yildiz A, Hursit M, Celik AV, Kayacan SM, Yazici H, Akkaya V, Gürol AO, Karsidag K. Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study. Clin Nephrol. 2002 Dec;58(6):405-10. doi: 10.5414/cnp58405.
• 28: Yildiz A, Tütüncü Y, Yazici H, Akkaya V, Kayacan SM, Sever MS, Carin M, Karşidağ K. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation. 2002 Oct 27;74(8):1109-13. doi: 10.1097/01.TP.0000031542.08424.85.
• 29: Yildiz A, Yazici H, Cine N, Akkaya V, Kayacan SM, Sever MS, Erginel-Unaltuna N. The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients. Clin Transplant. 2002 Jun;16(3):173-9. doi: 10.1034/j.1399-0012.2002.01058.x.
• 30: Yildiz A, Akkaya V, Tükek T, Sahin S, Sever MS, Bozfakioğlu S, Korkut F. Increased QT dispersion in hemodialysis patients improve after renal transplantation: a prospective-controlled study. Transplantation. 2001 Nov 15;72(9):1523-6. doi: 10.1097/00007890-200111150-00009.
• 31: Sever MS, Kazancioğlu R, Yildiz A, Türkmen A, Ecder T, Kayacan SM, Celik V, Sahin S, Aydin AE, Eldegez U, Ark E. Outcome of living unrelated (commercial) renal transplantation. Kidney Int. 2001 Oct;60(4):1477-83. doi: 10.1046/j.1523-1755.2001.00951.x.
• 32: Türk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A, Yeksan M. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001 Sep;16(9):1818-22. doi: 10.1093/ndt/16.9.1818.
• 33: Yildiz A, Cine N, Akkaya V, Sahin S, Ismailoğlu V, Türk S, Bozfakioğlu S, Sever MS. Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study. Transplantation. 2001 Aug 15;72(3):542-4. doi:10.1097/00007890-200108150-00035
• 34: Yildiz A, Akkaya V, Sahin S, Tükek T, Besler M, Bozfakioglu S, Korkut F. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients. Perit Dial Int. 2001 Mar-Apr;21(2):186-92.
• 35: Yildiz A, Akkaya V, Hatemi AC, Cine N, Tükek T, Görçin B, Demirel S, Türk S, Sever MS. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron. 2000 Feb;84(2):130-5. doi: 10.1159/000045560.
• 36: Sayiner A, Ece T, Duman S, Yildiz A, Ozkahya M, Kiliçaslan Z, Tokat Y.
• Tuberculosis in renal transplant recipients. Transplantation. 1999 Nov 15;68(9):1268-71. doi: 10.1097/00007890-199911150-00009..
• 37: Yildiz A, Erkoç R, Sever MS, Türkmen A, Ecder ST, Türk S, Kiliçarslan I, Ark
• E. The prognostic importance of severity and type of post-transplant
• proteinuria. Clin Transplant. 1999 Jun;13(3):241-4. doi:
• 10.1034/j.1399-0012.1999.130304.x. PMID: 10383104.
• 38: Yildiz A, Sever MS, Demirel S, Akkaya V, Türk S, Türkmen A, Ecder T, Ark E.
• Improvement of uremic autonomic dysfunction after renal transplantation: a heart
• rate variability study. Nephron. 1998 Sep;80(1):57-60. doi: 10.1159/000045126.
• PMID: 9730704.
• 39: Yildiz A, Sever MS, Türkmen A, Ecder T, Beşişik F, Tabak L, Ece T,
• Kiliçarslan I, Ark E. Tuberculosis after renal transplantation: experience of
• one Turkish centre. Nephrol Dial Transplant. 1998 Jul;13(7):1872-5. doi:
• 10.1093/ndt/13.7.1872. PMID: 9681753.